Source: Annual Congress 2007 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. A. Elliot, C. Billings, I. Armstrong, J. Waterhouse, C. Billings, M. Akil, D. G. Kiely (Sheffield, United Kingdom). Reduced incremental shuttle walking test distance is associated with a worse survival in pulmonary arterial hypertension associated with systemic sclerosis. Eur Respir J 2007; 30: Suppl. 51, 2081

Member's Comments

No comment yet.

Related content which might interest you: Incremental shuttle walking test distance predicts poor prognosis in pulmonary hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension Source: Eur Respir J 2012; 40: 1410-1419 Year: 2012 The change of lung diffusion capacity does not influence the prognosis in patients with pulmonary arterial hypertension associated with systemic sclerosis. Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Percent-predicted incremental shuttle walking test distance stratifies risk in pulmonary arterial hypertension Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 6-minute walk test predicts pulmonary artery pressure in patients with collagen vascular disease associated interstitial pneumonia Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Gas transfer relates to pulmonary haemodynamics and survival in pulmonary arterial hypertension associated with systemic sclerosis Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007 Incremental shuttle walking test distance is reduced in patients with pulmonary hypertension in WHO Functional Class I Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise Year: 2018 Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis Source: Eur Respir J 2016; 48: 1658-1667 Year: 2016 Effects of sildenafil on incremental shuttle walking test and haemodynamics in patients with pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 370s Year: 2002 Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension Source: Eur Respir J, 52 (4) 1800678; 10.1183/13993003.00678-2018 Year: 2018 Six-minute walk test correlates with hemodynamic severity in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 111s Year: 2004 Tadalafil improves exercise capacity and delays time to clinical worsening in patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension Year: 2008 Predictive value of combined metabolic and cardiopulmonary responses to estimate maximal aerobic impairment in patients with pulmonary arterial hypertension Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy Year: 2010 The incremental shuttle walk test in pulmonary hypertension Source: International Congress 2019 – Exercise tolerance and its determinants across pathologies Year: 2019 Reduced six-minute walking distance is associated with endothelial dysfunction in COPD patients Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011 Role of exercise cardiac index to predict NYHA functional class, 6-minute walk test distance and survival in idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Exercise oxygen uptake efficiency slope independently predicts poor outcome in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 1510-1512 Year: 2014 Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Is pulmonary arterial hypertension associated with interferon-ß therapy for multiple sclerosis reversible? A case study to explore the complexity Source: ERJ Open Res, 6 (1) 00328-2019; 10.1183/23120541.00328-2019 Year: 2020 6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2014; 43: 1421-1429 Year: 2014